Mark A Suckow
Inventor
Stats
- 8 US patents issued
- 13 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 13 US Applications Filed
- 56 Total Citation Count
- May 8, 2020 Most Recent Filing
- Aug 24, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Cook Biotech | 1
| 2010
|
University of Notre Dame | 1
1 5 2 4 4 | 2005
2006 2007 2008 2009 2010 |
UNIVERSITY OF NOTRE DAME DU LAC | 1
2 2 1 1 1 | 2005
2006 2007 2009 2010 2012 |
COOK BIOTECH INCORPORATED | 2
1 4 | 2007
2009 2010 |
Inventor Addresses
Address | Duration |
---|---|
Granger, IN | May 08, 08 - Oct 23, 08 |
Granger, IN, US | Sep 03, 09 - Apr 12, 16 |
Lexington, KY, US | Nov 12, 20 - Nov 12, 20 |
Notre Dame, IN, US | Mar 14, 13 - Mar 14, 13 |
South Granger, IN | Jul 03, 08 - Jul 03, 08 |
South Granger, IN, US | Mar 15, 16 - Mar 15, 16 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 13 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2020/0353,061 | 2020 | NEOANTIGEN PREPARATIONS AND USES THEREOF | 0 |
9308252 | 2016 | Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins | 16 |
9283266 | 2016 | Metastasis inhibition preparations and methods | 1 |
9220770 | 2015 | Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins | 0 |
8846059 | 2014 | Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.